John P. Condon | 617 348 4453 | jpcondon@mintz.com |
One Financial Center Boston, MA 02111 617-542-6000 617-542-2241 fax www.mintz.com |
November 16, 2017
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: | Dorrie Yale |
Mary Beth Breslin |
Re: | Albireo Pharma, Inc. |
Registration Statement on Form S-3 |
Filed October 13, 2017 |
File No. 333-220958 |
Ladies and Gentlemen:
On behalf of Albireo Pharma, Inc. (the Company), we are hereby filing with the Securities and Exchange Commission (the Commission) Amendment No. 1 (the Amendment) to the above-referenced Registration Statement on Form S-3 (the Registration Statement) and submitting this letter in response to the comments of the Staff of the Commissions Division of Corporation Finance (the Staff) given by letter (the Comment Letter) dated October 26, 2017 concerning the Registration Statement, which was filed with the Commission on October 13, 2017. Each response is numbered to correspond to the comment set forth in the Comment Letter, which for convenience, we have incorporated into this response letter. Page numbers referred to in the responses reference page numbers in the Amendment unless otherwise indicated.
Registration Statement on Form S-3
Cover Page
1. | Comment: Please revise your sales agreement prospectus supplement to clarify on the cover and in your Underwriting section that Cowen is or will be deemed rather than may be deemed an underwriter. |
Response: The Company acknowledges the Staffs comment and has revised the disclosure on the cover page and page SA-18 of the sales agreement prospectus included in the Amendment.
Plan of Distribution, page SA-18
2. | Comment: Your disclosure on the cover page of the prospectus supplement included in this registration statement states that sales may be made to or through a market maker, |
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
BOSTON | WASHINGTON | NEW YORK | STAMFORD | LOS ANGELES | PALO ALTO | SAN DIEGO | LONDON
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Page 2
in negotiated transactions, or any other method permitted by law. You also state in the Plan of Distribution in the prospectus supplement that sales may be made in privately- negotiated transactions if expressly authorized by you. Please tell us whether these other sales methods satisfy the at the market offering definition under Rule 415. If any sales method does not constitute a sales method that is deemed to be an at the market offering as defined in Rule 415 or if any material information with respect to a particular offering has been omitted, please confirm that you will file an additional prospectus supplement at the time of such sales or tell us why such additional filing would not be necessary. |
Response: The Company acknowledges the Staffs comment and has revised the disclosure on the cover page and pages SA-5 and SA-18 of the sales agreement prospectus included in the Amendment. The Company further confirms that, if any sales method employed by the Company does not constitute a sales method that is deemed to be an at the market offering, as defined in Rule 415, or if any material information with respect to a particular offering has been omitted from the sales agreement prospectus included in the Registration Statement, the Company will file an additional prospectus supplement at the time of such sale.
We hope that the above responses are acceptable to the Staff. Please do not hesitate to call the undersigned at 617-348-4453 with any comments or questions regarding this response letter. We thank you for your time and attention.
Very truly yours, |
/s/ John P. Condon, Esq. |
John P. Condon, Esq. |
cc: | Albireo Pharma, Inc. |
Peter A. Zorn, Esq., Chief Corporate Officer, General Counsel and Secretary
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Megan N. Gates, Esq.
R'^S[Y^?LK$_<<]AZ_F.^.K\%P^)-/UK6SJF M@O!;:GJ#7<RD%6U92".A!MH>:ZRN#^%WA#4/!6G:OI5\_G1_;S);7&[/F MQ>6@4XZ@C;C'MQQ7>4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 <0 4444 %%%% !1110 4444 %%%% !1110!__V0$! end